Home
About
Overview
Sharing Data
ORCID
Help
History (1)
The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy.
The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy. Blood. 2011 Feb 10; 117(6):1928-37.
View in:
PubMed
subject areas
Aniline Compounds
Aniline Compounds
Apoptosis
Apoptosis
Benzocycloheptenes
Benzocycloheptenes
Binding Sites
Binding Sites
B-Lymphocytes
B-Lymphocytes
Coculture Techniques
Coculture Techniques
Humans
Humans
Leukemia, Lymphocytic, Chronic, B-Cell
Leukemia, Lymphocytic, Chronic, B-Cell
Myeloid Cell Leukemia Sequence 1 Protein
Myeloid Cell Leukemia Sequence 1 Protein
Nitriles
Nitriles
Phosphorylation
Phosphorylation
Protein Kinase Inhibitors
Protein Kinase Inhibitors
Protein Kinases
Protein Kinases
Proto-Oncogene Proteins
Proto-Oncogene Proteins
Proto-Oncogene Proteins c-bcl-2
Proto-Oncogene Proteins c-bcl-2
Quinolines
Quinolines
Receptor Protein-Tyrosine Kinases
Receptor Protein-Tyrosine Kinases
src-Family Kinases
src-Family Kinases
Stromal Cells
Stromal Cells
Triazoles
Triazoles
authors with profiles
Asish K Ghosh